MIH
NVO

Meitav Investment House’s Novo Nordisk NVO Stock Holding History

Meitav Investment House’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-449,302
Closed -$46.5M – 317
2023
Q4 		$46.5M Buy
449,302
+39,954
+10% +$3.95M 0.68% 44
2023
Q3 		$37.7M Buy
409,348
+361,530
+756% +$31.8M 0.61% 52
2023
Q2 		$3.75M Sell
47,818
-8,100
-14% -$662K 0.06% 142
2023
Q1 		$4.49M Sell
55,918
-10,180
-15% -$722K 0.08% 144
2022
Q4 		$4.46M Sell
66,098
-34,500
-34% -$2.02M 0.08% 150
2022
Q3 		$5.04M Sell
100,598
-760
-0.7% -$40.7K 0.09% 142
2022
Q2 		$5.63M Sell
101,358
-5,006
-5% -$278K 0.1% 137
2022
Q1 		$5.95M Sell
106,364
-35,324
-25% -$1.81M 0.09% 151
2021
Q4 		$7.9M Sell
141,688
-2,654
-2% -$144K 0.13% 132
2021
Q3 		$6.93M Buy
144,342
+57,854
+67% +$2.8M 0.11% 140
2021
Q2 		$3.62M Buy
86,488
+18,468
+27% +$716K 0.09% 143
2021
Q1 		$2.4K Buy
68,020
+23,500
+53% +$837K 0.07% 151
2020
Q4 		$1.55M Hold
44,520
– – 0.06% 139
2020
Q3 		$1.55M Hold
44,520
– – 0.08% 125
2020
Q2 		$1.46M Buy
+44,520
New +$1.42M 0.09% 118

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meitav Investment House's NVO Position: Q1 2024 in Review

Meitav Investment House sold out of Novo Nordisk (NVO) in Q1 2024, closing a stake of 449,302 shares — an estimated $46.5M sold.

Meitav Investment House first reported a position in NVO in Q2 2020 and held it in 15 quarters. The position peaked at $46.5M in Q4 2023. 1,744 funds tracked by Wall St. Rank hold NVO as of Q1 2024.

  • Meitav Investment House reported no remaining Novo Nordisk position as of Q1 2024 after selling out during the quarter.
  • Meitav Investment House sold 449,302 Novo Nordisk shares in Q1 2024, an estimated $46.5M.
  • Meitav Investment House first reported a position in Novo Nordisk in Q2 2020 and held it in 15 quarters.
  • Meitav Investment House's Novo Nordisk position peaked at $46.5M in Q4 2023.
  • 1,744 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2024.

Based on Meitav Investment House's 13F filing for Q1 2024, filed 1 May 2024.